Quantitative Magnetic Resonance And Optical Imaging Biomarkers Of Melanoma Metastatic Potential

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 16, 2009, Pages 6608-6613

  Li, Lin Z ^a   Zhou, Rong ^a   Xu, He N ^a   Moon, Lily ^a   Zhong, Tuoxiu ^a   Kim, Eun Ju ^a   Qiao, Hui ^a   Reddy, Ravinder ^a   Leeper, Dennis ^b   Chance, Britton ^a   Glickson, Jerry D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dynamic contrast enhanced MRI; Human melanoma xen ografts; Invasive potential; Mitochondrial redox state; T1rho

Indexed keywords

BIOLOGICAL MARKER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TUMOR MARKER; CONTRAST MEDIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CELL STRAIN A375P; CELL STRAIN C8161; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LOW TEMPERATURE PROCEDURES; LUNG; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PRIORITY JOURNAL; TUMOR BIOPSY; XENOGRAFT; ANIMAL; DRUG SCREENING; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PATHOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MITOCHONDRIA; NEOPLASM METASTASIS; OXIDATION-REDUCTION; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 66149145314     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901807106     Document Type: Article

References (45)

1. Gershenwald JE, et al. (1999) Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976-983.
2. Balch CM, et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648.
3. Balch CM, et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [see comment]. J Clin Oncol 19:3622-3634.
4. Thompson JF, Shaw HM, Hersey P, Scolyer RA (2004) The history and future of melanoma staging. J Surg Oncol 86:224-235.
5. Thompson JF, Stretch JR, Uren RF, Ka VS, Scolyer RA (2004) Sentinel node biopsy for melanoma: Where have we been and where are we going? Ann Surg Oncol 11(Suppl):147S-151S.
6. Seftor EA, Seftor REB, Hendrix MJC (1990) Selection of invasive and metastatic sub-populations from a heterogeneous human melanoma cell line. BioTechniques 9:324-331.
7. Hendrix MJC, Seftor EA, ChuYW, Trevor KT, Seftor REB (1996) Role of intermediate filaments in migration, invasion, and metastasis. Cancer Metastasis Rev 15:507-525.
8. Hendrix MJ, et al. (1992) Coexpression of vimentin and keratins by human melanoma tumor cells: Correlation with invasive and metastatic potential. J Natl Cancer Inst 84:165-174.
9. Kozlowski JM, Hart IR, Fidler IJ, Hanna N (1984) A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 72:913-917.
10. Nagashima T, et al. (2002) Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 9:226-230.
11. Duvvuri U, et al. (2001) Water magnetic relaxation dispersion in biological systems: The contribution of proton exchange and implications for the noninvasive detection of cartilage degradation. Proc Natl Acad Sci USA 98:12479-12484.
12. 1ρ . J Cereb Blood Flow Metab 20:1457-1466.
13. Kettunen MI, Brindle KM (2005) Apoptosis detection using magnetic resonance imaging and spectroscopy. Prog Nucl Magn Reson Spectrosc 47:175-185.
14. 1ρ relaxation time increases immediately upon global ischemia in the rat independently of blood glucose and anoxic depolarization. Magn Reson Med 46:565-572.
15. 1ρ relaxation in rat brain. Magn Reson Med 48:470-477.
16. Quistorff B, Haselgrove JC, Chance B (1985) High-resolution readout of 3D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument. Anal Biochem 148:389-400.
17. Li LZ, et al. (2007) Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Oxygen Transport to Tissue XXVIII , eds Maguire DJ, Bruley DF, Harrison DK (Springer, New York), Vol 599, pp 67-78.
18. Xu HN, et al. (2009) Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Oxygen Transport to Tissue XXX , eds Liss P, Hansell P, Bruley DF, Harrison DK (Springer, New York), Vol 645, pp 247-253.
19. Zhou R, Pickup S, Yankeelov TE, Springer CS, Glickson JD (2004) Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: Effects of transcytolemmal water exchange. Magn Reson Med 52:248-257.
20. Pickup S, Zhou R, Glickson J (2003) MRI estimation of the arterial input function in mice. Acad Radiol 10:963-968.
21. Yankeelov TE, Luci JJ, DeBusk LM, Lin PC, Gore JC (2008) Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: Theory, simulations, and experimental results. Magn Reson Med 59:326-335.
22. Yankeelov TE, et al. (2005) Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology. NMR Biomed 18:173-185.
23. Yankeelov TE, Rooney WD, Li X, Springer CS, Jr (2003) Variation of the relaxographic ''shutter-speed'' for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn Reson Med 50:1151-1169.
24. Kim S, et al. (2007) Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck. J Magn Reson Imaging 26:1607-1617.
25. Li X, et al. (2005) Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease. Magn Reson Med 53:724-729.
26. Tofts PS, Beerkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 33:564-568.
27. Tofts PS, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 10:223-232.
28. Makela HI, Grohn OHJ, Kettunen MI, Kauppinen RA (2001) Proton exchange as a relaxation mechanism for T 1 in the rotating frame in native and immobilized protein solutions. Biochem Biophys Res Commun 289:813-818.
29. 1ρ dispersion weighted Nmr spectroscopy. Magn Reson Med 12:390-399.
30. Chance B, Schoener B, Oshino R, Itshak F, Nakase Y (1979) Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluores-cence signals. J Biol Chem 254:4764-4771.
31. Rofstad EK (2000) Microenvironment-induced cancer metastasis. Int J Radiat Biol 76:589-605.
32. Subarsky P, Hill RP (2003) The hypoxic tumor microenvironment and metastatic progression. Clin Exp Metastasis 20:237-250.
33. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM (2002) MRI of the tumor microenvironment. J Magn Reson Imaging 16:430-450.
34. Vaupel P, Mayer A (2007) Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26:225-239.
35. Dewhirst MW, et al. (2005) Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Int J Radiat Oncol Biol Phys 61:480-491.
36. Cavalli LR, Liang BC (1998) Mutagenesis, tumorigenicity, and apoptosis: Are the mitochondria involved? Mutat Res 398:19-26.
37. Modica-Napolitano JS, Singh KK (2004) Mitochondrial dysfunction in cancer. Mito-chondrion 4:755-762.
38. Chance B, Williams GR (1955) A method for the localization of sites for oxidative phosphorylation. Nature 176:250-254.
39. Chance B, Baltscheffsky H (1958) Respiratory enzymes in oxidative phosphorylation. J Biol Chem 233:736-739.
40. Zhang Q, et al. (2006) Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci USA 103:9029-9033.
41. Bristow RG, Hill RP (2008) Hypoxia, DNA repair, and genetic instability. Nat Rev Cancer 8:180-192.
42. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ (2006) Acid-mediated tumor invasion: A multidisciplinary study. Cancer Res 66:5216-5223.
43. Welch DR, et al. (1991) Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 47:227-237.
44. 1ρ dispersion in the human brain at 1.5 tesla. J Magn Reson Imaging 19:403-409.
45. 1ρ using a multislice spin-lock pulse sequence. Magn Reson Med 52:1453-1458.